Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:40 UTC |
---|
HMDB ID | HMDB0014602 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Acitretin |
---|
Description | Acitretin is only found in individuals that have used or taken this drug. It is an oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate (PubChem). The mechanism of action of acitretin is unknown, however it is believed to work by targeting specific receptors (retinoid receptors such as RXR and RAR) in the skin which help normalize the growth cycle of skin cells. |
---|
Structure | COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1 InChI=1S/C21H26O3/c1-14(8-7-9-15(2)12-21(22)23)10-11-19-16(3)13-20(24-6)18(5)17(19)4/h7-13H,1-6H3,(H,22,23)/b9-7+,11-10+,14-8+,15-12+ |
---|
Synonyms | Value | Source |
---|
(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid | ChEBI | Acitretina | ChEBI | Acitretine | ChEBI | Acitretinum | ChEBI | all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid | ChEBI | Etretin | ChEBI | Neotigason | ChEBI | Soriatane | ChEBI | (all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoate | Generator | all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoate | Generator | Isoacitretin | HMDB | 13-cis-Acitretin | HMDB | Acitretin, (Z,e,e,e)-isomer | HMDB | Isoetretin | HMDB | Acetretin | HMDB | Acitretin andreu brand | HMDB | Acitretin roche brand | HMDB | Hoffmann la roche brand OF acitretin | HMDB | Hoffmann-la roche brand OF acitretin | HMDB | Andreu brand OF acitretin | HMDB | Roche brand OF acitretin | HMDB | (2E,4E,6E,8E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid | HMDB | Acitretinoin | HMDB | all-trans-Acitretin | HMDB | Acitretin | HMDB |
| Show more...
---|
Chemical Formula | C21H26O3 |
---|
Average Molecular Weight | 326.4293 |
---|
Monoisotopic Molecular Weight | 326.188194698 |
---|
IUPAC Name | (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid |
---|
Traditional Name | acitretin |
---|
CAS Registry Number | 55079-83-9 |
---|
SMILES | COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1 |
---|
InChI Identifier | InChI=1S/C21H26O3/c1-14(8-7-9-15(2)12-21(22)23)10-11-19-16(3)13-20(24-6)18(5)17(19)4/h7-13H,1-6H3,(H,22,23)/b9-7+,11-10+,14-8+,15-12+ |
---|
InChI Key | IHUNBGSDBOWDMA-AQFIFDHZSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as retinoids. These are oxygenated derivatives of 3,7-dimethyl-1-(2,6,6-trimethylcyclohex-1-enyl)nona-1,3,5,7-tetraene and derivatives thereof. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Prenol lipids |
---|
Sub Class | Retinoids |
---|
Direct Parent | Retinoids |
---|
Alternative Parents | |
---|
Substituents | - Retinoic acid
- Retinoid skeleton
- Sesquiterpenoid
- Cyclofarsesane sesquiterpenoid
- Phenoxy compound
- Anisole
- Methoxybenzene
- Phenol ether
- Medium-chain fatty acid
- Styrene
- Alkyl aryl ether
- Branched fatty acid
- Methyl-branched fatty acid
- Monocyclic benzene moiety
- Fatty acyl
- Fatty acid
- Benzenoid
- Unsaturated fatty acid
- Monocarboxylic acid or derivatives
- Ether
- Carboxylic acid
- Carboxylic acid derivative
- Carbonyl group
- Organooxygen compound
- Organic oxide
- Organic oxygen compound
- Hydrocarbon derivative
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 228 - 230 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.00048 g/L | Not Available | LogP | 5.7 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized | Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Acitretin GC-MS (Non-derivatized) - 70eV, Positive | splash10-03di-1279000000-d74bbc0348cfdb3b3732 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Acitretin GC-MS (1 TMS) - 70eV, Positive | splash10-001i-4139000000-85e857f30a345651bb66 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Acitretin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Acitretin LC-ESI-qTof , Positive-QTOF | splash10-01t9-0592000000-92a48c620c961fdb430f | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Acitretin , positive-QTOF | splash10-056r-1943000000-77c18bcac662a9f6bdcb | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Acitretin , positive-QTOF | splash10-056r-2942000000-57cdf186555912258599 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Acitretin 10V, Positive-QTOF | splash10-05r0-0389000000-28f8ff224c8fd7ac1606 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Acitretin 20V, Positive-QTOF | splash10-02t9-0690000000-11440b22373ebd567609 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Acitretin 40V, Positive-QTOF | splash10-114j-4920000000-bf257c11adfb644686f4 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Acitretin 10V, Negative-QTOF | splash10-004i-0059000000-2338c505b394d676d7a4 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Acitretin 20V, Negative-QTOF | splash10-0059-0097000000-d73443e0cee4f07fd0d9 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Acitretin 40V, Negative-QTOF | splash10-066r-3391000000-8adb8a7f90aecb16b198 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Acitretin 10V, Negative-QTOF | splash10-001j-0092000000-da6b1640ed88e8dd0629 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Acitretin 20V, Negative-QTOF | splash10-017j-1291000000-8d03b8e6cfa817060924 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Acitretin 40V, Negative-QTOF | splash10-00dj-1494000000-45aa9916567486569a90 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Acitretin 10V, Positive-QTOF | splash10-0ke9-0395000000-2d28d3c86a8a16a5adac | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Acitretin 20V, Positive-QTOF | splash10-03di-0940000000-2f4d9396336fd697861e | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Acitretin 40V, Positive-QTOF | splash10-00tf-1900000000-f5a87d3a7b17af3487e6 | 2021-09-25 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Membrane
|
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00459 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00459 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB00459 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB023099 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | Not Available |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Acitretin |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 5284513 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 50173 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
---|